Israel Englander’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Israel Englander’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-50,000	Closed	-$2.29M	–	4789
2019 Q3	$2.29M	Sell	50,000 -10,000	-17%	-$562K	﹤0.01%	2360
2019 Q2	$3.52M	Buy	+60,000	New	+$3.1M	0.01%	2054
2018 Q2	–	Sell	-228,300	Closed	-$9.02M	–	4323
2018 Q1	$9.02M	Buy	+228,300	New	+$8.88M	0.01%	1407
2017 Q3	–	Sell	-51,700	Closed	-$872K	–	4002
2017 Q2	$872K	Buy	+51,700	New	+$709K	﹤0.01%	2514

Israel Englander's ARNA Position: Q1 2022 in Review

Israel Englander sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 557,746 shares — an estimated $51.8M sold.

Israel Englander first reported a position in ARNA in Q2 2013 and held it in 33 quarters. The position peaked at $51.8M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Israel Englander reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Israel Englander sold 557,746 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $51.8M.
Israel Englander first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 33 quarters.
Israel Englander's Arena Pharmaceuticals Inc position peaked at $51.8M in Q4 2021.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Millennium Management's 13F filing for Q1 2022, filed 16 May 2022.